Diabetes Outcomes in COVID-19 Pandemic

Diabetes Clinical Trial

Official title:

Health-related Outcomes and Behaviour Changes in a Cohort of Diabetic Population During COVID-19 Pandemic: Results of a Telephonic Survey

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04573335
• Other study ID #: 16102019
• Status: Completed
• Start date: June 1, 2020
• Est. completion date: July 30, 2020

Study information

• Verified date: September 2020
• Source: Services Institute of Medical Sciences, Pakistan
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Diabetes management and follow-up has become a challenge during the COVID-19 pandemic. Nation-wide lockdowns and social distancing measures adopted in an attempt to break the chain of COVID-19 transmission have significantly disrupted routine care and follow-up of diabetes. In the health sector, especially in low-income countries such as Pakistan, there has been a shift of resources and staff reassignment from stable chronic illnesses to support COVID-19 pandemic. Disruption of routine outpatient health services and travel restrictions increase the risk of worsening diabetes control and diabetes-related health outcomes. Additionally, social isolation amidst an atmosphere of fear and uncertainty contributes to stress further affecting glycaemic control.

Description:

An observational cross-sectional study was conducted using telephone interview method in Diabetes Management Centre (DMC), Services hospital, Lahore. The study participants were 1282 diabetic patients selected randomly from electronic medical record (EMR) database of the Centre. A structured questionnaire was used to evaluate parameters which included patients' demographic information; diabetes self-care and general health profile; COVID-related questions and its impact on quality of life (QoL); financial and social support issues.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1282
• Est. completion date: July 30, 2020
• Est. primary completion date: July 15, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• Type 1 and type 2 diabetic patients registered with Diabetes Management Centre, Services hospital, Lahore, Pakistan.

Exclusion Criteria:

• Patients lacking telephonic contact or with invalid contact numbers.

Related Conditions & MeSH terms

• Covid19
• Diabetes
• Diabetes Mellitus
• Isolation, Social

Locations

Country	Name	City	State
Pakistan	Services Hospital	Lahore	Punjab

Sponsors (1)

Lead Sponsor	Collaborator
Services Institute of Medical Sciences, Pakistan

Country where clinical trial is conducted

Pakistan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	All-cause mortality	Death due to diabetes-related complications or otherwise	during 3months of lockdown
Secondary	COVID-19 illness	%age of participants with one or more symptoms of fever, sore throat, cough, dyspnoea	During 3months of lockdown